Manufacturers Life Insurance Company, The Unity Biotechnology, Inc. Transaction History

Manufacturers Life Insurance Company, The

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$4.15 - $6.3 $97,371 - $147,816	-23,463 Closed	0 $0
Q1 2021 May 03, 2021	SELL	$5.51 - $9.42 $3,300 - $5,642	-599 Reduced 2.49%	23,463 $141,000
Q4 2020 Feb 12, 2021	BUY	$3.42 - $6.36 $11,005 - $20,466	3,218 Added 15.44%	24,062 $126,000
Q2 2020 Aug 10, 2020	BUY	$5.28 - $9.67 $6,314 - $11,565	1,196 Added 6.09%	20,844 $181,000
Q1 2020 May 15, 2020	BUY	$5.0 - $7.6 $9,840 - $14,956	1,968 Added 11.13%	19,648 $114,000
Q4 2019 Feb 14, 2020	SELL	$5.99 - $8.38 $3,737 - $5,229	-624 Reduced 3.41%	17,680 $127,000
Q3 2019 Nov 12, 2019	BUY	$5.62 - $9.63 $691 - $1,184	123 Added 0.68%	18,304 $114,000
Q2 2019 Aug 14, 2019	BUY	$7.59 - $10.21 $137,993 - $185,628	18,181 New	18,181 $173,000

4.41M

Ticker UBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,036,200
Market Cap $14M
Description
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular d...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.